角膜新血管化的管理:当前和新兴的治疗方法
Duoduo Wu1, Kai En Chan2, Blanche Xiao Hong Lim1,2
1Department of Ophthalmology, National University Hospital, Singapore.
Indian journal of ophthalmology
|April 22, 2024
概括
角膜新血管化 (CoNV) 是视力丧失的主要原因,它带来了治疗挑战. 本综述探讨了针对冠状病毒的当前和新型疗法,旨在改善患者的治疗结果.
科学领域:
- 眼科医生 眼科 眼科
- 血管生物学 血管生物学
- 再生医学是一种再生医学.
背景情况:
- 角膜新血管化 (CoNV) 是视力损伤的重要原因,每年影响数百万,预计将增加.
- 冠状病毒源于诸如角膜炎,烧伤,干细胞缺乏,创伤和移植拒绝等病理状况.
- 这种情况是由于益血管性和抗血管性因素的不平衡造成的,涉及复杂的分子通路.
研究的目的:
- 审查用于角膜新血管化 (CoNV) 的传统和新兴治疗策略.
- 总结当前关于CovNV治疗方法的证据,强调局限性和未来方向.
主要方法:
- 系统地审查现有的关于 CoNV 治疗方法的文献.
- 分析常规疗法,包括皮质类固醇.
- 评估针对分子机制和外科干预的新兴治疗方法.
主要成果:
- 皮质类固醇是标准的,但有效性有限,特别是在成熟的CoNV.
- 先进的成像和更深入的病原遗传理解正在推动新的治疗方法.
- 当代治疗侧重于不同的分子点和手术选择.
结论:
- 对冠状病毒病毒的有效治愈疗法仍然难以捉摸.
- 新兴疗法显示出解决当前治疗方法的局限性的前景.
- 对分子机制和创新干预措施的进一步研究对于管理CoNV至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
440
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
440
Angle Closure Glaucoma: Treatment
485
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
485


